Literature DB >> 23836538

Distribution of transglutaminase 6 in the central nervous system of adult mice.

Yu-Tao Liu1, Bei-Sha Tang, Wei Lan, Ning-Ning Song, Ying Huang, Lei Zhang, Wen-Juan Guan, Yu-Ting Shi, Lu Shen, Hong Jiang, Ji-Feng Guo, Kun Xia, Yu-Qiang Ding, Jun-Ling Wang.   

Abstract

Our previous study identified a new form of spinocerebellar ataxia (SCA), in which mutations in the gene coding for transglutaminase 6 (TG6) were suggested to be causative. However, the data concerning cellular distribution of TG6 in the brain is still fragmentary. Therefore, we now report a comprehensive immunohistochemical examination of the expression profile of TG6 in adult mouse brain. TG6 was abundantly expressed in the septal region, basal ganglia, hypothalamus and brainstem. Notably, numerous TG6-positive neurons were found in the key brain regions involved in regulating locomotion activity, including the globus pallidus, subthalamic nucleus, substantia nigra, cerebellum, some precerebellar nuclei, and spinal motor neurons. Double immunostaining showed that the vast majority of TG6-positive neurons in the reticular nigra were GABAergic and those in the compact nigra were not dopaminergic. In addition, double staining for TG6 with either anti-NeuN or glial fibrillary acidic protein (GFAP) antibodies demonstrated exclusive NeuN-TG6 co-localization. This study presents a comprehensive overview of TG6 expression in the mouse brain, and provides insight for investigating the role of TG6 in the development of SCA.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  brain; distribution; immunohistochemistry; spinocerebellar ataxia; transglutaminase 6

Mesh:

Substances:

Year:  2013        PMID: 23836538     DOI: 10.1002/ar.22741

Source DB:  PubMed          Journal:  Anat Rec (Hoboken)        ISSN: 1932-8486            Impact factor:   2.064


  6 in total

Review 1.  Transglutaminases: part I-origins, sources, and biotechnological characteristics.

Authors:  Lovaine Duarte; Carla Roberta Matte; Cristiano Valim Bizarro; Marco Antônio Záchia Ayub
Journal:  World J Microbiol Biotechnol       Date:  2020-01-02       Impact factor: 3.312

2.  The gliadin peptide 31-43 exacerbates kainate neurotoxicity in epilepsy models.

Authors:  Elisabetta Gerace; Francesco Resta; Elisa Landucci; Daniela Renzi; Alessio Masi; Domenico E Pellegrini-Giampietro; Antonio Calabrò; Guido Mannaioni
Journal:  Sci Rep       Date:  2017-11-09       Impact factor: 4.379

Review 3.  Gluten and Autism Spectrum Disorder.

Authors:  Iain D Croall; Nigel Hoggard; Marios Hadjivassiliou
Journal:  Nutrients       Date:  2021-02-09       Impact factor: 5.717

Review 4.  Transglutaminase 3: The Involvement in Epithelial Differentiation and Cancer.

Authors:  Elina S Chermnykh; Elena V Alpeeva; Ekaterina A Vorotelyak
Journal:  Cells       Date:  2020-08-30       Impact factor: 6.600

5.  Cognitive Impairment in Coeliac Disease with Respect to Disease Duration and Gluten-Free Diet Adherence: A Pilot Study.

Authors:  Iain D Croall; Claire Tooth; Annalena Venneri; Charlotte Poyser; David S Sanders; Nigel Hoggard; Marios Hadjivassiliou
Journal:  Nutrients       Date:  2020-07-08       Impact factor: 5.717

Review 6.  A Breakdown of Immune Tolerance in the Cerebellum.

Authors:  Christiane S Hampe; Hiroshi Mitoma
Journal:  Brain Sci       Date:  2022-02-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.